Legal status by country
Is Adropin legal?
Written by Aaron CuhaReviewed Sep 2026
How Adropin is classified in the United States, United Kingdom, Australia and Canada, side by side. Each country has its own page with a direct answer, the regulator's approval status and what the classification means in practice.
All four countries, side by side
| Attribute | United States · FDA | United Kingdom · MHRA | Australia · TGA | Canada · Health Canada |
|---|---|---|---|---|
| Status | Not approved | Not approved | Not approved | Not approved |
| Classification | Not a medicine; endogenous signalling molecule | Not a medicine; endogenous signalling molecule | Not a medicine; endogenous signalling molecule | Not a medicine; endogenous signalling molecule |
| Note | No approved drug targets adropin or its proposed receptor. Every registered human study measures adropin as an outcome rather than giving it. | Research analyte, not a medicine. | Research analyte, not a medicine. | Research analyte, not a medicine. |
US FDA status: Not a drug. Adropin is an endogenous peptide measured in research studies. No adropin product is approved anywhere and no interventional human trial has been registered.. Reviewed Sep 2026.
Related compounds
General information current as of Sep 2026, not legal advice. Classifications change; confirm with the regulator or a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships.